Cyclin D1 and D3 expression in melanocytic skin lesions.

Authors:
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G and 1 more

Journal:
Arch Dermatol Res

Publication Year: 2010

DOI:
10.1007/s00403-010-1054-3

PMCID:
PMC2913004

PMID:
20496072

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Arch Dermatol Res

Abbreviation: Arch Dermatol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Fractional Er:YAG laser versus fractional CO2 laser in the treatment of immature and mature scars: …
Osman MA; Kassab AN. (2024) - Transparency Score: 3/6
Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alop…
Mogawer RM; Fawzy MM; Mourad A and 4 more (2024) - Transparency Score: 4/6
A history of asthma is associated with susceptibility to hidradenitis suppurativa: a population-bas…
Kridin K; Shihade W; Weinstein O and 4 more (2023) - Transparency Score: 3/6
Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-…
Nayak D; Srivastava N; Dev A and 4 more (2023) - Transparency Score: 3/6
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale…
Liu M; Wu M; Liu X and 7 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest None."

Evidence found in paper:

"The study was supported by research grant 501/NKL/145/L from Jagiellonian University Medical College."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025